Loading clinical trials...
Loading clinical trials...
An Open Label Randomised Controlled Study to Evaluate the Induction of Immune Memory Following Infant Vaccination With a Glycoconjugate Neisseria Meningitidis Serogroup C Vaccine and to Assess the Immunological Impact of Administering Routine Infant Immunisations in Consistent Versus Alternating Limbs
Conditions
Interventions
Glyco-conjugate Neisseria meningitidis serogroup C (MenC) vaccine
Routine schedule immunisations except monovalent MenC vaccine
Locations
1
United Kingdom
Oxford Vaccine Group
Oxford, United Kingdom
Start Date
June 1, 2010
Primary Completion Date
July 1, 2013
Last Updated
November 9, 2015
Lead Sponsor
University of Oxford
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions